A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China
Clinical trial NCT04162275 · COMPLETED
Trial details
- NCT number
- NCT04162275
- Sponsor
- Yiling Pharmaceutical Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2018-04-27
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.